We Exhibited at PALETTE Enichi — Connections Made in Otemachi, Tokyo
- 6月1日
- 読了時間: 2分
Sharing the Potential of "the Eye" at the Otemachi Festival
Humanity Vision exhibited at the PALETTE "Enichi" (Festival of Connections), hosted in Otemachi — Tokyo's premier business district. The event chose a traditional Japanese festival format to create an open, welcoming atmosphere among some of Japan's most established corporate headquarters. What we experienced there was the power of conveying digital health technology through direct, personal experience.
The "30-Second Surprise" That Drew a Crowd
Our EYE TELL booth embraced the casual accessibility of a festival stall. Using just a smartphone browser — no hardware, no download required — the demo analyzes pupil responses and detects signals for 6 conditions plus full-body vitals in just 30 seconds. This demonstration exceeded the expectations of nearly every attendee who tried it.
Reactions varied widely. Executives from major corporations told us it made "the value of investing in preventive medicine tangible." Startup founders asked how the technology could be integrated into their products. Investors noted the high potential for B2B deployment. The informal atmosphere of the festival setting enabled open conversations that a formal boardroom rarely allows.
Potential with Toyota Group, Pipeline from Sumitomo Corporation
Two encounters stood out above the rest.
The first was a conversation with representatives from Toyota Group. The application of EYE TELL to driver fatigue and health monitoring — and its role as an early-detection digital health layer inside vehicles — quickly moved into concrete discussions about a Proof of Concept trial. The insight: the "eye" could become a gateway to protecting driver safety and wellbeing, right inside the car.
The second was a connection with Sumitomo Corporation. Through their network, a referral pipeline to medical institutions and corporate partners took shape, creating a new foothold for domestic B2B expansion in Japan.
The Essence of Business Development, as Revealed by Enichi
In Japanese business culture, "ご縁" (connection) is not mere social courtesy — it is the foundation of trust. A live experience of "try it yourself" and "feel it for yourself" builds deeper relationships than any formal sales pitch in a meeting room.
What the Enichi revealed: the value of technology is only truly communicated through experience — not explanation. In healthcare especially, because the information is directly connected to one's own body, the act of trying it matters more than any chart or data sheet.
Toward Early Detection in Preventive Medicine — The Next Step
EYE TELL is a screening and early detection device currently under FDA De Novo review. Its role is not to treat, but to create moments of "awareness," "detection," and "action." The conversations at Otemachi revealed that this technology has potential well beyond clinical settings — enterprise health screenings, transportation, insurance, and diverse B2B applications. By reading the "universal biomarker" of the pupil, we can bring more people a meaningful first step toward preventive healthcare.
Honoring these new connections, we continue to deepen relationships with medical institutions and corporate partners across Japan, expanding the value of early detection.
To the Next Connection
Every connection made at the festival is a first step toward future collaboration. To everyone who expressed interest in building the future of preventive medicine and digital biomarkers alongside EYE TELL — thank you. We look forward to what comes next.
